Publications scientifiques sur le VIH
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.
2005
AIDS.
Falutz J, Allas S, Kotler D, et al.
19(12):1279-1287.
Effects of TH9507, a growth hormone-releasing factor (GRF) analog, on the quality of life of HIV-infected patients with abdominal fat accumulation.
2005
Falutz J, Allas S, Dragano N, et al.
Poster #L-167 presented at: the 12th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2005; Boston, Massachusetts, USA.
Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.
2004
J Infect Dis.
Kuritzkes DR, Jacobson J, Powderly WG, et al.
189(2):286-291.
Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.
2004
Int J Pharm.
Jansen M, Darby I, Abribat T, et al.
276(1-2):75-81.